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Objective:Minimizing surgical access in reoperative cardiac surgery allows limitation of dissection, trauma, and
manipulation of patent bypass grafts. We report an 11-year experience with reoperative minimal access aortic
valve surgery through an upper hemisternotomy.
Methods: From July 1996 to June 2007 at our institution, 146 patients underwent reoperative minimal access
aortic valve surgery, 109 of whom had undergone previous coronary artery bypass grafting and 93 of whom
had a patent left internal thoracic artery graft. In patients with a patent left internal thoracic artery graft, the graft
remained undissected. Myocardial protection was achieved with hypothermia, cold cardioplegia, and systemic
hyperkalemia. Early and late outcomes were analyzed.
Results: Median age was 76 years, and 43 patients (29%) were 80 years or older. Nineteen patients(13%) un-
derwent concomitant procedures, such as coronary artery bypass grafting, mitral valve repair, and ascending aor-
tic replacement. Median cardiopulmonary bypass and aortic crossclamp times were 150 and 80 minutes,
respectively. Four patients (2.8%) had conversion to full sternotomy. Operative mortality was 4.1% (6/146).
The incidences of reoperation for bleeding and blood transfusion were 0.7% (1/146) and 83.6% (122/146), re-
spectively. No patient had left internal thoracic artery or aortocoronary graft injury. Median stay was 8 days, and
56% (79/140) were discharged home. Five-year actuarial survival was 85%.
Conclusion: An upper hemisternotomy approach for reoperative aortic valve surgery is safe and feasible. This
approach minimizes tissue dissection and trauma, thereby reducing the risk of injury to patent grafts and medi-
astinal organs.The frequency of reoperative cardiac surgery is increasing as
patients live longer and more bioprosthetic valves are used.
The major concerns in reoperative cardiac surgery are bleed-
ing and mediastinal organ injury. Dissection of adherent
tissue, the heart, and great vessels increases the amount of
blood loss and subsequent blood transfusion requirement.
During a reoperation after previous coronary artery bypass
grafting (CABG), a key concern would be disturbing a pat-
ent, adherent coronary artery graft, particularly, the left inter-
nal thoracic artery (ITA) to left anterior descending artery
graft, because this may lead to graft flow disruption, ische-
mia, dissection, or restenosis. Minimal access approaches
minimize mediastinal dissection and handling of friable
tissues on sternal reentry, resulting in reduced transfusion
requirement and decreased operative time relative to a full
sternotomy.1 For patients with patent grafts, this approach
minimizes the risk of graft injury. left ITA grafts are not
dissected, and other aortocoronary grafts are exposed only
at their proximal part, which is usually identified without
difficulty.2
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institution since 1996 for reoperative aortic valve surgery.
We sought to assess the early and late outcomes of reopera-
tive minimal access aortic valve surgery (ReMAAVS).
MATERIALS AND METHODS
Patient Data
We conducted a retrospective review of 146 consecutive patients who
underwent ReMAAVS between July 1996 and June 2007 at Brigham and
Women’s Hospital. In addition, we reviewed the cases of 150 patients
who underwent isolated reoperative aortic valve surgery through a full ster-
notomy during the same period. Perioperative data were collected from pa-
tient medical records and the Brigham and Women’s Hospital Cardiac
Surgery Database according to The Society of Thoracic Surgeons National
Adult Cardiac Database version 2.52 definitions. A hybrid procedure was
defined as ReMAAVS within 24 hours after a percutaneous coronary inter-
vention, and the detailed methodology has been previously published by our
group.3 The number of transfused units of blood products was defined as the
sum of blood products transfused from skin incision to discharge. Late sur-
vival data were collected from National Social Security Number Database.
Continuous values are expressed as medians. This study was approved by
the institutional review board of Brigham and Women’s Hospital (protocol
number 2005p000324), and a waiver of informed consent was obtained.
Indications for ReMAAVS and Preoperative
Assessment
The reoperative upper hemisternotomy approach can be used for aortic
valve and ascending aortic surgery.We successfully performed concomitant
edge-to-edge repair of the mitral valve through the aortic annulus; however,
this approach is not appropriate if a patient requires other concomitant pro-
cedures. We have performed a few cases of reoperative aortic root replace-
ment through an upper hemisternotomy; however, we currently do not use
this approach for reoperative aortic root replacement, because the exposurergery c December 2008




CABG ¼ coronary artery bypass grafting
ITA ¼ internal thoracic artery
ReMAAVS ¼ reoperative minimal access aortic
valve surgery
TEE ¼ transesophageal echocardiography
of the aortic root is difficult. Additionally, this approachwould not be appro-
priate for a patient who cannot have a transvenous pacing wire (eg,
mechanical tricuspid valve). In our institution, the approach selection (upper
hemisternotomy vs full sternotomy) in reoperative aortic valve surgery
largely depends on the surgeon’s preference. Some surgeons exclusively
use an upper hemisternotomy, whereas others use a full sternotomy.
Hybrid procedures were performed in selected high-risk patients with
moderate coronary artery disease. Further follow-up is necessary, however,
to establish the indications for a hybrid procedure.3
In patients with patent ITA grafts, we routinely performed a 3-dimen-
sional computed assisted tomographic scan to assess the anatomic relation-
ship between grafts and sternum. We used contrast medium unless a patient
had renal insufficiency.
Surgical Procedure of ReMAAVS
All patients received external defibrillator pads, underwent intraopera-
tive transesophageal echocardiography (TEE), and had a pulmonary arterial
catheter with pacing ports placed unless specific contraindications existed.
All patients underwent peripheral cannulation for cardiopulmonary bypass
before resternotomy.Most patients underwent right axillary arterial and per-
cutaneous femoral venous cannulation.
The upper sternum was divided down to the fourth intercostal space in
the midline and then divided transversely to the right, at the fourth intercos-
tal space. Cardiopulmonary bypass was started before the posterior sternal
table was divided. Mediastinal dissection was limited to the ascending aorta
for clamping and aortotomy, right atrial appendage for retrograde cardiople-
gia, and right superior pulmonary vein for venting. The in situ ITA grafts
were not approached; only the proximal parts of the aortocoronary grafts
were dissected. A retrograde cardioplegic cannula (under TEE guidance)
and a venting cannula were placed (Figure 1).
On cardiopulmonary bypass, patients without a patent left ITA graft were
systemically cooled to 28C to 34C, and those with a patent left ITA graft
were cooled down to 20C to 25C. Cooling should be started after it is pos-
sible to place an aortic crossclamp. After standard aortic crossclamping,
myocardial arrest was obtained with a combination of cold antegrade and
retrograde cardioplegia with additional systemic hyperkalemia. Systemic
hyperkalemia was accomplished by instilling potassium chloride into the
cardiopulmonary bypass circuit and was maintained at a level of 6.0 to
7.0 mEq/L. Ultrafiltration was used to clear the high level of potassium after
release of the aortic crossclamp. Left ventricular distention was continu-
ously monitored with TEE. Left ventricular venting was accomplished
through the right superior pulmonary vein or through the aortic annulus after
aortotomy. The aortic valve operation was then performed with standard
techniques according to patient indications (Figure 2). When backflow
from the patent left ITA–left anterior descending artery graft through the
left main ostium obscured the operative field, pump flows were temporarily
turned down to improve surgical field view. Rewarmingwas started after the
aortic valve was seated. The aortotomy was closed, and the aortic cross-
clamp was released.
Defibrillation was achieved through the external pads. In addition to
standard deairing maneuvers, external compressions and table positioning
helped in removal of intracardiac air, as confirmed by TEE. Carbon dioxide
was blown in the mediastinal space during aortic crossclamping to minimizeThe Journal of Thoracic and Cthe risk of air embolism.4 Temporary epicardial pacing wires were placed on
the anterior surface of the right ventricle before the aortic crossclamp was
removed, with the heart completely decompressed if possible. In most cases,
we placed transvenous pacing electrodes through the pulmonary artery cath-
eter. All patients received drainage tubes placed through the right pleural
space. Cardiopulmonary bypass weaning, decannulation, and chest closure
were done in a standard fashion.
RESULTS
Preoperative Characteristics
Median patient age was 76 years (range 27–93 years), and
43 patients (29%) were 80 years old or older. Among 146
patients, 109 had previously undergone CABG, and 93
had patent left ITA grafts. Other preoperative characteristics
of patients are shown in Table 1.
Operative Variables
One hundred thirty-seven patients underwent stented
aortic bioprosthetic valve replacements, 37 underwent me-
chanical valve replacements, 3 underwent stentless aortic
FIGURE 1. Skin and sternal incisions (top) and cannulation (bottom) in
reoperative minimal access aortic valve surgery.ardiovascular Surgery c Volume 136, Number 6 1565
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valve repair. Six patients underwent hybrid procedures, 5
underwent annular enlargement, 5 underwent concomitant
mitral valve repair (edge-to-edge repair through the aortic
valve annulus), and 4 underwent concomitant ascending aor-
tic replacement. Four patients (2.7%) had conversion to
a full sternotomy during surgery. The reasons for conversion
included poor exposure of the aortic valve, right ventricular
tear from pacing wire placement, right ventricular failure,
and sustained ventricular fibrillation after release of the aor-
tic crossclamp. The median cardiopulmonary bypass and
aortic crossclamp times were 150 and 80 minutes, respec-
tively (including nonisolated aortic valve operations). In
a subgroup of patients with patent left ITA grafts who had
systemic hyperkalemia, intraoperative hemofiltration was al-
most routinely used to clear high potassium level; however
no patient required new postoperative dialysis.
Early and Late Outcomes
The operative mortality was 4.1% (6/146). There were 5
cardiac deaths and 1 neurologic death. There was no
incidence of left ITA or aortocoronary graft injury. The in-
cidences of postoperative complications and blood transfu-
sion requirements are shown in Table 2. The bleeding site
FIGURE 2. Aortic valve exposure in reoperative minimal access aortic
valve surgery (surgeon’s view).
TABLE 1. Preoperative patient characteristics (N ¼ 146)
Age (y, median and range) 76 (27–93)
Male (No.) 115 (78.8%)
More than 1 previous operation (No.) 13 (8.9%)
Previous coronary artery bypass grafting (No.) 109 (74.7%)
Patent internal thoracic artery graft (No.) 93 (63.7%)
Previous aortic valve replacement (No.) 33 (22.6%)
Ejection fraction (%, median and range) 55 (10–80)
Nonelective surgery (No.) 13 (8.9%)
Aortic stenosis (No.) 100 (68.5%)
Aortic insufficiency (No.) 29 (19.9%)
Aortic stenosis and insufficiency (No.) 17 (11.6%)1566 The Journal of Thoracic and Cardiovascular Suof 1 patient who required reexploration was the right ITA.
Median hospital stay was 8 days, and 56% (79/140) were
discharged directly home. Five-year actuarial survival was
85%.
In the elderly subgroup (80 years old), the operative
mortality was 2.3% (1/43). The incidences of postoperative
complications and blood transfusion requirements are
shown in Table 2. Median stay in this subgroup was 9
days, and 33.3% (14/42) were discharged directly home.
Full Sternotomy Approach
We used a full sternotomy approach in 150 reoperative
isolated aortic valve operations. Among these cases, 62 pa-
tients had previously undergone CABG, and 50 had patent
ITA grafts. In those cases, the mediastinal dissection was
minimized, and ITA grafts were not approached.5 Median
age was 68 years (range 20–90 years). Median cardiopulmo-
nary bypass and aortic crossclamp times were 145 and 83
minutes, respectively (including only isolated aortic valve
operations). The operative mortality was 4.6% (7/150),
and the blood transfusion requirement rate was 83.3%
(125/150). There were 3 left ITA graft injuries at the time
of sternal entry or mediastinal dissection.
DISCUSSION
Our 11-year, single-institution experience of ReMAAVS
indicates that a minimal access approach is safe and feasible
for reoperative aortic valve surgery. The benefits of a mini-
mal access approach in aortic valve operations include
shorter stay,6-9 more discharges directly to home,6-8 less in-
cisional pain,10,11 shorter duration of ventilation,7,8,10 and
less blood loss7-10,12 and blood transfusion8 than with
a full sternotomy. Avoiding a full sternotomy should






Operative death (No.) 6 (4.1%) 1 (2.3%)
Graft injury (No.) 0 (0%) 0 (0%)
Reoperation for bleeding (No.) 1 (0.7%) 1 (2.3%)
Deep sternal wound infection (No.) 1 (0.7%) 0 (0%)
Prolonged postoperative
ventilation (>24 h, No.)
21 (14.4%) 9 (20.9%)
Pneumonia (No.) 3 (2.1%) 0 (0%)
Blood transfusion (No.) 122 (83.6%) 39 (90.7%)
Red blood cell transfusion
Patients transfused (No.) 115 (78.8%) 37 (86.0%)
Median transfusion (units) 3 4
Fresh-frozen plasma transfusion
Patients transfused (No.) 69 (47.3%) 15 (34.9%)
Median transfusion (units) 3 2
Platelet transfusion
Patients transfused (No.) 47 (32.2%) 13 (30.2%)
Median transfusion (units) 6 6rgery c December 2008
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less incisional pain. Better-preserved stability of the sternum
may prevent deep infection, help recovery of respiratory
function, and aid in early mobility in the immediate postop-
erative period.13 Our data indicate low incidences of deep
sternal wound infection and pneumonia, which would sup-
port this assumption. Furthermore, a minimal access ap-
proach in reoperative surgery provides additional benefits,
such as minimizing the risk of injury to mediastinal organs
and patent grafts. Our series did not have any left ITA or aor-
tocoronary graft injuries. We had no mediastinal organ in-
juries during reoperative sternotomy and dissection. In full
sternotomy cases, even though we minimized the mediasti-
nal dissection and did not approach the left ITA graft, there
were some left ITA graft injuries. Because the mediastinal
organs or patent grafts can be very close to the upper ster-
num, we further recommend a routine assessment of the geo-
graphic and anatomic relations of grafts by imaging. Grafts
may lie in unusually close proximity to critical structures
that may need to be dissected or divided during the
operation. As we described here, we routinely perform 3-
dimensional computed assisted tomography before surgery,
which is very useful in showing the anatomic relationship
between patent grafts and sternum for building the surgical
strategy.14
In our series, the blood transfusion rate with a minimal ac-
cess approach was relatively high, similar to that with a full
sternotomy approach. This finding does not support the con-
jecture that a minimal access approach reduces bleeding or
blood transfusion requirement. The high blood transfusion
rate could be explained by the longer cardiopulmonary by-
pass times during a partial sternotomy and systemic hypo-
thermia (especially in patients with a patent ITA graft).
Myocardial protection in patients with patent left ITA
grafts was obtained during cardiac asystole with systemic
cooling, antegrade and retrograde cardioplegia, and sys-
temic hyperkalemia. Retrograde cardioplegia is essential in
patients with previous CABG. In a nonreoperative situation,
we occasionally abort placement of retrograde cardioplegia
cannula to avoid coronary sinus injury.15 In a reoperative sit-
uation, coronary sinus injury is unlikely to occur because of
fibrous adhesion of the posterior heart.
Limited access may provide insufficient exposure of the
aortic valve. In our series, we had only 1 case that required
conversion to a full sternotomy because of poor exposure.
We saw right ventricular injury from pacing wire placement,
which required conversion to a full sternotomy for repair.
We therefore now avoid placement of epicardial pacing
wires and routinely use a pulmonary artery catheter with
pacing ports. It is difficult to use internal defibrillation pad-
dles in reoperative minimal access procedures. Appropriate
and accurate positioning of external pads is thus extremely
important. We had 4 converted cases (2.7%). In our entire
minimal access experience with an upper hemisternotomy,The Journal of Thoracic and Cthe conversion rate was 2.6% to 2.7%.13,15 This reoperative
conversion rate is similar to that seen with a primary minimal
access aortic valve surgical approach.
There have been a limited number of reports of
ReMAAVS. Bakir and colleagues16 reported on 19 cases
of reoperative aortic valve replacement through an upper
hemisternotomy and showed favorable results. Their surgi-
cal strategy was almost the same as ours, except that they
often used central aortic cannulation. Sharony and col-
leagues17 reported on reoperative valve operations through
a minithoracotomy, including 61 aortic valve operations.
In their study, the minimal access group had similar cardio-
pulmonary and aortic crossclamp times, a lower incidence of
wound infection, and a shorter hospital stay than the full ster-
notomy group.
A limitation of this study is its noncomparative nature.
We did not statistically compare our ReMAAVS outcomes
with those of conventional reoperative aortic valve surgery,
because the approach selection was strongly surgeon spe-
cific and it was difficult to properly adjust this confounding
factor.
In conclusion, a minimal access approach is safe and fea-
sible in reoperative aortic valve surgery, with excellent early
and late outcomes. This approach minimizes tissue dissec-
tion and trauma, thereby reducing the risk of injury to patent
grafts and mediastinal organs.
We thank SiobhanMcGurk, who assisted us with data collection
and management.
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